BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 31563815)

  • 1. A combined molecular biology and network pharmacology approach to investigate the multi-target mechanisms of Chaihu Shugan San on Alzheimer's disease.
    Zeng Q; Li L; Siu W; Jin Y; Cao M; Li W; Chen J; Cong W; Ma M; Chen K; Wu Z
    Biomed Pharmacother; 2019 Dec; 120():109370. PubMed ID: 31563815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Network pharmacology-based strategy to investigate pharmacological mechanisms of Tinospora sinensis for treatment of Alzheimer's disease.
    Zhou F; He K; Guan Y; Yang X; Chen Y; Sun M; Qiu X; Yan F; Huang H; Yao L; Liu B; Huang L
    J Ethnopharmacol; 2020 Sep; 259():112940. PubMed ID: 32389853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network Pharmacology and Experimental Evidence: PI3K/AKT Signaling Pathway is Involved in the Antidepressive Roles of Chaihu Shugan San.
    Zhang S; Lu Y; Chen W; Shi W; Zhao Q; Zhao J; Li L
    Drug Des Devel Ther; 2021; 15():3425-3441. PubMed ID: 34385814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network pharmacology-based study on the mechanism of
    Kun C; Feiyi S; Jian D; Feng C; Guihua W; Jiangping Z; Jianwu J; Hong L; Xiaowei H
    Indian J Pharmacol; 2020; 52(2):94-101. PubMed ID: 32565596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncovering the active compounds and effective mechanisms of the dried mature sarcocarp of Cornus officinalis Sieb. Et Zucc. For the treatment of Alzheimer's disease through a network pharmacology approach.
    Qu YJ; Zhen RR; Zhang LM; Gu C; Chen L; Peng X; Hu B; An HM
    BMC Complement Med Ther; 2020 May; 20(1):157. PubMed ID: 32450873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Mechanism of Kai Xin San on Alzheimer's Disease Based on Network Pharmacology and Experimental Validation.
    Wang K; Yang R; Chen TT; Qin MR; Wang P; Kong MW
    Chin J Integr Med; 2023 May; 29(5):413-423. PubMed ID: 36474082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p38 MAPK signal pathway involved in anti-inflammatory effect of Chaihu-Shugan-San and Shen-ling-bai-zhu-San on hepatocyte in non-alcoholic steatohepatitis rats.
    Yang Q; Xu Y; Feng G; Hu C; Zhang Y; Cheng S; Wang Y; Gong X
    Afr J Tradit Complement Altern Med; 2014; 11(1):213-21. PubMed ID: 24653580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A network-based analysis of key pharmacological pathways of Andrographis paniculata acting on Alzheimer's disease and experimental validation.
    Gu L; Lu J; Li Q; Wu N; Zhang L; Li H; Xing W; Zhang X
    J Ethnopharmacol; 2020 Apr; 251():112488. PubMed ID: 31866509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncovering the mechanism of the Shenzhi Jiannao formula against vascular dementia using a combined network pharmacology approach and molecular biology.
    Tian D; Gao Q; Lin J; Chang Z; Wang Y; Shi Y; Su R; Han Z; Ma D
    Phytomedicine; 2021 Sep; 90():153637. PubMed ID: 34273705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chaihu-shugan san inhibits inflammatory response to improve insulin signaling in liver and prefrontal cortex of CUMS rats with glucose intolerance.
    Jia KK; Pan SM; Ding H; Liu JH; Zheng YJ; Wang SJ; Pan Y; Kong LD
    Biomed Pharmacother; 2018 Jul; 103():1415-1428. PubMed ID: 29864926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Network Pharmacological Approach to Investigate the Mechanism of Action of Active Ingredients of Epimedii Herba and Their Potential Targets in Treatment of Alzheimer's Disease.
    Li Y; Yang Q; Yu Y
    Med Sci Monit; 2020 Sep; 26():e926295. PubMed ID: 32980851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Naodesheng tablets on amyloid beta-induced dysfunction: A traditional Chinese herbal formula with novel therapeutic potential in Alzheimer's disease revealed by systems pharmacology.
    Zhang B; Zhao J; Guo P; Wang Z; Xu L; Liu A; Du G
    Biomed Pharmacother; 2021 Sep; 141():111916. PubMed ID: 34328103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated network pharmacology analysis and serum metabolomics to reveal the cognitive improvement effect of Bushen Tiansui formula on Alzheimer's disease.
    Zhang Z; Yi P; Yang J; Huang J; Xu P; Hu M; Zhang C; Wang B; Peng W
    J Ethnopharmacol; 2020 Mar; 249():112371. PubMed ID: 31683034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease.
    Uddin MS; Kabir MT; Niaz K; Jeandet P; Clément C; Mathew B; Rauf A; Rengasamy KRR; Sobarzo-Sánchez E; Ashraf GM; Aleya L
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32168835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on hepatoprotective mechanisms of Veratrilla baillonii based on network pharmacology].
    He CJ; Wang J; Liang S; Li J; Huang XJ
    Zhongguo Zhong Yao Za Zhi; 2020 Apr; 45(8):1789-1799. PubMed ID: 32489062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systems pharmacology-based approach to investigate the mechanisms of Danggui-Shaoyao-san prescription for treatment of Alzheimer's disease.
    Wu Q; Chen Y; Gu Y; Fang S; Li W; Wang Q; Fang J; Cai C
    BMC Complement Med Ther; 2020 Sep; 20(1):282. PubMed ID: 32948180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective role of Dihydromyricetin in Alzheimer's disease rat model associated with activating AMPK/SIRT1 signaling pathway.
    Sun P; Yin JB; Liu LH; Guo J; Wang SH; Qu CH; Wang CX
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30498091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated meta-analysis, network pharmacology, and molecular docking to investigate the efficacy and potential pharmacological mechanism of Kai-Xin-San on Alzheimer's disease.
    Yi P; Zhang Z; Huang S; Huang J; Peng W; Yang J
    Pharm Biol; 2020 Dec; 58(1):932-943. PubMed ID: 32956608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated network pharmacology and zebrafish model to investigate dual-effects components of Cistanche tubulosa for treating both Osteoporosis and Alzheimer's Disease.
    Li YQ; Chen Y; Fang JY; Jiang SQ; Li P; Li F
    J Ethnopharmacol; 2020 May; 254():112764. PubMed ID: 32173426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological Targets and the Biological Mechanisms of Formononetin for Alzheimer's Disease: A Network Analysis.
    Xiao H; Qin X; Wan J; Li R
    Med Sci Monit; 2019 Jun; 25():4273-4277. PubMed ID: 31175839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.